HSG

New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Normunity is a biotechnology company focused on developing precision immuno-oncology medicines, specifically a new class known as immune normalizers. These medicines aim to target novel mechanisms that enhance the body’s natural immune response against cancer. In collaboration with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is researching newly-discovered mechanisms of immune disruption in cancer, utilizing proprietary discovery platforms to explore the intricate interactions between cancer and the immune system. The company is advancing a pipeline of immune normalizers, which includes initial drug programs designed to address the exclusion of T-cells from immune-sensitive tumors and other factors that impede normal immune function in cancer. Normunity operates from locations in Boston, Massachusetts, and West Haven, Connecticut.

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Cloudphysician is a prominent provider of Smart-ICU services, utilizing a cloud-based platform to enhance critical care delivery. The company employs advanced technologies such as artificial intelligence, the Internet of Things, and predictive analytics to facilitate real-time clinical decision-making. This innovative approach supports early-stage diagnosis of critical diseases in adults and monitors immunization schedules and growth profiles of newborns, aimed at reducing neonatal mortality rates. By combining medical expertise with technology, Cloudphysician improves patient outcomes and offers hospitals and healthcare providers enhanced monitoring, support, and training, ultimately transforming the landscape of critical care in the healthcare industry.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Generation Lab is focused on enhancing human health through the development of biological age testing services. The company aims to create a test that accurately assesses an individual's biological age and associated disease risks, utilizing clinically applicable biological evidence. By providing clinical-grade longevity reports and health span data analysis, Generation Lab enables healthcare professionals to optimize specific health areas based on the latest genomic research. The goal is to empower individuals to live longer and healthier lives by gaining insights into their biological age progression.

Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

Spear Bio is a biotechnology company established in 2021 and located in Weston, Massachusetts. The company specializes in ultrasensitive protein detection technology, which provides significant advantages in the healthcare sector. Its innovations support self-testing and telemedicine-based diagnostics by enabling the quantification of minute protein biomarkers from samples collected at home. This approach allows clinicians to achieve ultrasensitive detection using small sample volumes, seamlessly integrating into existing workflows for sample collection, processing, and analysis.

FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.

Yangqi Intelligent provides answers for medical equipment. It provides goods like qise, elixir, wonder vision, odd control, and more. A self-made radiation body surface monitoring camera is called wonder vision. Qice is a platform for artificial intelligence-based medical models. Sales.

Neurowyzr specializes in brain healthcare by offering a platform that focuses on the detection, diagnosis, therapy, monitoring, and prevention of cognitive decline. The company's innovative approach provides healthcare providers with evidence-based tools aimed at enhancing awareness of brain health. By facilitating early intervention and promoting preventive measures, Neurowyzr seeks to transform societal attitudes towards brain health, ultimately enabling individuals to manage and maintain their cognitive well-being effectively.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

Noah Medical is a manufacturer of medical robotic devices aimed at enhancing the diagnosis and treatment of patients in various healthcare settings. The company's innovative devices facilitate early diagnoses and treatments, particularly in advanced clinical environments. By enabling hospitals to address medical issues promptly, Noah Medical's technology contributes to improved patient outcomes and minimizes scarring associated with procedures.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

NeuroXess is a high-tech life science company focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain.

Yangqi Intelligent provides answers for medical equipment. It provides goods like qise, elixir, wonder vision, odd control, and more. A self-made radiation body surface monitoring camera is called wonder vision. Qice is a platform for artificial intelligence-based medical models. Sales.

RedBrick AI is a software-as-a-service platform focused on annotating medical data, particularly in the field of radiology. It offers specialized web-based annotation tools for both 2D and 3D medical imagery, which can be seamlessly integrated into existing data storage systems used by healthcare providers. The platform is designed to streamline the annotation process by allowing clinicians to access robust tools directly through their browsers. Additionally, it features functionalities such as workflow control, user management, task assignment, and custom validation checks. These capabilities enable hospitals and medical associations to efficiently manage annotations and facilitate their integration with machine learning operations, ultimately supporting the development of healthcare artificial intelligence.

FitBudd is a software as a service (SaaS) platform based in Gurgaon, Haryana, that supports health and fitness coaches in growing their businesses internationally. It provides an all-in-one trainer portal that allows fitness professionals to manage clients, create personalized training and nutrition plans, and track client progress. By enhancing client engagement and retention, FitBudd enables trainers to offer tailored fitness sessions and promote a healthier lifestyle. The platform also increases the visibility of fitness coaches, making them more accessible to a global clientele, thereby facilitating their business expansion.

Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

WuXi Bo Rui Biotechnology develops a radioactive molecular imaging and nuclear drug transformation platform for the precise diagnosis and treatment of tumors. WuXi Bo Rui Biotechnology focuses on the transformation and development of new radionuclide drugs, covering multiple fields of small molecules, peptides, and antibodies, for the diagnosis and treatment of tumors, using their professional platform for targeted precursor design, screening, and radionuclide labeling. While increasing the efficiency of research and development, it also fully utilizes the benefits of accurate nuclear medicine diagnosis and treatment

Frontera Therapeutics is a company specializing in adeno-associated virus (AAV) gene therapy, focused on developing and commercializing cost-effective recombinant virus-based therapies. The company aims to create a scalable platform that produces high-quality, affordable rAAV therapies for a range of genetic disorders, including ophthalmic, liver, metabolic, and neuromuscular diseases. Frontera Therapeutics has a diverse product pipeline that encompasses multiple therapeutic areas, with various candidates at different stages of development. By prioritizing affordability and quality, the company seeks to enhance the lives of patients through innovative genetic therapies.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

DigitAlp is a scientific and technical innovation company focused on enhancing the value of clinical research through a comprehensive digital solution tailored for institutions. The company offers an integrated platform consisting of four key modules: an institutional comprehensive management system, a trial electronic medical record system designed for research wards, a sponsor service system, and a subject recruitment and full-service system. This suite of tools enables various stakeholders in clinical research to manage their operations more efficiently, ultimately streamlining the entire clinical trial process.

Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.

NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.

Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.

Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.

Hao Microbiology is a developer of vascular interventional embolization products.

CureFun is an online education portal specializing in medical education services. The company provides a comprehensive platform for medical students that includes training process management, theoretical learning, self-assessment, and examination services. Additionally, CureFun offers intelligent question bank recommendations to enhance the learning experience. Their innovative platform features realistic simulations of clinical scenarios, allowing students to practice and develop critical clinical thinking skills through interactive virtual exercises. This blend of theoretical knowledge and practical application positions CureFun as a valuable resource for aspiring medical professionals.

Xmov is a company that specializes in developing artificial reality animation solutions, focusing on virtual human and content creation tailored for enterprise users across various Metaverse applications. The company employs advanced motion capture, animation, and artificial intelligence technologies to deliver customized interactive solutions for diverse business scenarios. Additionally, Xmov creates a comprehensive infrastructure for 3D virtual content production, providing full-stack technology and product services aimed at facilitating education, employment, and the development of virtual world platforms. Their innovative approach spans multiple sectors, including entertainment, cultural tourism, e-commerce, finance, education, healthcare, and communications, establishing a multifaceted ecological development model.

Xmov is a company that specializes in developing artificial reality animation solutions, focusing on virtual human and content creation tailored for enterprise users across various Metaverse applications. The company employs advanced motion capture, animation, and artificial intelligence technologies to deliver customized interactive solutions for diverse business scenarios. Additionally, Xmov creates a comprehensive infrastructure for 3D virtual content production, providing full-stack technology and product services aimed at facilitating education, employment, and the development of virtual world platforms. Their innovative approach spans multiple sectors, including entertainment, cultural tourism, e-commerce, finance, education, healthcare, and communications, establishing a multifaceted ecological development model.

XISOFT is a professional manufacturer specializing in informatization and data services within health economic management. The company develops an enterprise resource planning (ERP) platform tailored for hospitals, providing comprehensive management and monitoring capabilities across various functions, including finance, supply chain, human resources, and diagnosis-related groups. By leveraging technology, XISOFT aims to support medical institutions in streamlining operations and enhancing efficiency. Its platform enables effective business integration and refined management, addressing key areas such as intelligent finance, material assets, internal control, and event management. Through its innovative solutions, XISOFT assists healthcare providers in realizing their strategic objectives and improving overall operational effectiveness.

Grit Science is a biotechnology company specializing in gene therapeutics, particularly focusing on the research and development of liver-related genes. The firm is dedicated to creating medical products and genetic treatments that address clinical needs and enhance human health. Through its innovative approach to biopharmaceutical technology, Grit Science aims to contribute significantly to the field of medicine by developing solutions that improve patient outcomes.

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

HemaCell is a cell therapy company specializing in the in vitro regeneration of hematopoietic lineages, including blood and immune cells. Founded by experts with extensive experience in the field, the company utilizes advanced stem cell reprogramming and differentiation technologies to develop innovative solutions. HemaCell is focused on addressing the pressing demand for platelets in the treatment of various conditions, such as cancer, liver disease, critical illnesses, and hematological disorders. Additionally, the company is dedicated to creating new therapeutic drugs targeting diseases associated with platelet abnormalities, thereby offering effective treatment options for patients.

Sirka is Indonesia's pioneering metabolic clinic, focused on healthcare innovation through a technology-enabled, holistic approach to managing obesity and metabolic health. The clinic addresses the root causes of weight gain and chronic diseases, offering services that include weight management, digestive health, diabetes care, and chronic disease management. Sirka provides personalized, clinically proven programs tailored to individual needs, combining expert medical care with customized nutrition plans and continuous monitoring. Clients can connect with dietitians through an application, allowing them to set health goals and receive meal plan recommendations as part of structured programs. Sirka aims to empower Indonesians to lead healthier lives by improving weight management and enhancing control over chronic conditions.

the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

NeuroXess is a high-tech life science company focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain.

Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

Hevo Data Inc. is a software-as-a-service company specializing in data integration services. Founded in 2016 and headquartered in San Francisco, California, with an additional office in Bengaluru, India, Hevo offers a platform that allows users to connect and transfer data from diverse sources, including databases, cloud storage, cloud applications, and streaming services. The platform also facilitates the analysis of data across various formats and silos. Hevo Data serves a wide range of industries, including fintech, hospitality, e-commerce, healthcare, and edtech, among others. The company's automated data pipeline solutions are designed to simplify and enhance data management for organizations.

Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.

Dangsheng New Material is a high-performance fiber material developer and a high-tech enterprise dedicated to the development, production and sales of high-performance fiber materials. It has realized the production of China's only high-performance anti-virus and biochemical barrier protective clothing made of a single material. . Dangsheng New Materials provides a series of medical disposable protective products, including protective clothing, isolation clothing, protective shoe covers and other supplies.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care and innovative techniques. Founded by former consultant surgeons from prestigious institutions, along with professionals from the technology and business sectors, the company aims to enhance patient outcomes and streamline the surgical experience. Pristyn Care specializes in advanced laser surgeries across various medical fields, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By leveraging cutting-edge technology and implementing efficient operational processes, Pristyn Care seeks to create a comprehensive ecosystem that organizes and optimizes day care procedures, ultimately improving recovery times and overall health for patients.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

BDG is a specialist hospital focusing on the diagnosis and treatment of brain diseases, brain health management, and brain neurology research.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.

ComGen Pharma is a biotechnology company that specializes in the research and development of innovative therapeutic drugs targeting the complement system. The company aims to create effective immunotherapies for autoimmune diseases and tumors by focusing on new and key targets within this biological pathway. Recently, ComGen Pharma secured nearly 100 million yuan in financing, which will primarily support phase I clinical trials for its complement inhibitors, advance its drug pipeline, and enhance its innovative drug research and development platform. The financing round was led by prominent investors, including Sequoia China and Yahui Investment, with additional support from Fuchuang Investment and Renyou Investment.

Mosaic Wellness is a digital health platform that operates a collection of health clinics focused on enhancing well-being for specific demographics in India. The company aims to empower individuals through personalized solutions that address particular health needs. It offers services such as medical consultations, wellness assessments, and hygiene products, all accessible via its digital platform. Each clinic, including those targeting men and women, strives to provide essential resources that support a fulfilling and healthy lifestyle. Mosaic Wellness is dedicated to helping individuals navigate their health journeys with a focus on purpose and wellness.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Cellular Biomedicine Group, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company employs proprietary cell-based technologies, including various forms of CAR-T therapy, which targets different cancer types, and human adipose-derived mesenchymal progenitor cells aimed at treating joint diseases. Its product pipeline features therapies such as CD20 and CD22 CAR-T for B cell malignancies, and alpha fetoprotein TCR-T targeting hepatocellular carcinoma. Additionally, Cellular Biomedicine is developing knee osteoarthritis treatments, including AlloJoin and Re-Join, the latter having completed Phase IIb trials. The company also engages in broader biopharmaceutical activities, encompassing research and development, technical support, and manufacturing of pharmaceutical polypeptides and medical devices. It has established a partnership with Novartis Pharma AG to produce and supply the CAR-T cell therapy Kymriah in China. Founded in 2001, Cellular Biomedicine Group is headquartered in New York, New York, and draws on a wealth of cellular medicine research and expertise from scientists and clinicians across the United States, England, and China.

MetWare is a developer of advanced metabolic technology that focuses on metabolism analysis and testing services for various health conditions, including cancer, metabolic disorders, and infectious diseases. The company utilizes innovative metabolomics technology to enhance life science research and medical applications. By providing clinical testing products and data analysis, MetWare aims to support healthcare professionals in delivering effective treatment to patients. Their commitment to applying cutting-edge technology in the medical field positions them as a significant contributor to improving health outcomes through detailed metabolic insights.

Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Yuanxin Huibao is a health insurance technology service provider that specializes in medical insurance, particularly for major and chronic diseases. The company offers a comprehensive suite of services that includes special drug services, video consultations, welfare drugs, and claims investigations. By integrating these features, Yuanxin Huibao aims to deliver reliable medical services and improve insurance coverage for its users. Additionally, the company provides insurance firms with a one-stop solution for risk control and actuarial pricing, enhancing the overall efficiency and effectiveness of the health insurance process.

Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.

Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in cell therapy, focusing on developing innovative treatments for rare diseases, cancer, and various immunological and metabolic disorders. Central to its approach is the REDx platform, which utilizes engineered red blood cell technology. This platform enables the genetic engineering of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. By leveraging this technology, Westlake Therapeutics aims to create personalized therapies that enhance treatment options for patients facing a wide range of health challenges.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Zenyum is a Singaporean start-up established in 2018 that focuses on enhancing dental experiences through technology and innovation. The company aims to improve smiles across Asia by offering high-quality dental products, including 3D-printed invisible braces. Zenyum collaborates with a network of professional dentists to provide customers with safe, effective, and affordable clear teeth aligning devices. By transforming traditional dental routines into engaging experiences, Zenyum is committed to making dental care accessible and enjoyable for everyone.

XISOFT is a professional manufacturer specializing in informatization and data services within health economic management. The company develops an enterprise resource planning (ERP) platform tailored for hospitals, providing comprehensive management and monitoring capabilities across various functions, including finance, supply chain, human resources, and diagnosis-related groups. By leveraging technology, XISOFT aims to support medical institutions in streamlining operations and enhancing efficiency. Its platform enables effective business integration and refined management, addressing key areas such as intelligent finance, material assets, internal control, and event management. Through its innovative solutions, XISOFT assists healthcare providers in realizing their strategic objectives and improving overall operational effectiveness.

Analytical Biosciences focuses on the development of single-cell genome technologies to enhance the understanding and treatment of human diseases. By collaborating with medical research institutions, hospitals, and pharmaceutical companies, the company leverages single-cell genomics and bioinformatics to create detailed maps of diseases. This approach allows for large-scale systematic disease mapping and the mining of extensive data sets, which aids partners in identifying new therapeutic targets and formulating innovative treatment strategies. Analytical Biosciences employs high-resolution databases and advanced data analytics to facilitate the discovery and validation of novel cellular targets and biomarkers, ultimately contributing to the development of next-generation therapeutics and diagnostics.

Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. The company specializes in drug discovery and early development, primarily in the fields of immuno-oncology and eye diseases. Phanes Therapeutics is developing a range of therapeutic molecules, including a monoclonal antibody aimed at treating solid tumors, as well as therapies for age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, the company is working on bispecific antibodies targeting small cell lung cancer. Through its extensive scientific expertise and innovative approaches, Phanes Therapeutics aims to create effective treatment options that enhance patient care and improve outcomes for those suffering from various conditions.

Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care and innovative techniques. Founded by former consultant surgeons from prestigious institutions, along with professionals from the technology and business sectors, the company aims to enhance patient outcomes and streamline the surgical experience. Pristyn Care specializes in advanced laser surgeries across various medical fields, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By leveraging cutting-edge technology and implementing efficient operational processes, Pristyn Care seeks to create a comprehensive ecosystem that organizes and optimizes day care procedures, ultimately improving recovery times and overall health for patients.

PackGene Biotech, LLC is a biotechnology company based in the United States that specializes in developing viral vectors for gene therapies. It primarily focuses on adeno-associated virus (AAV) vectors, offering comprehensive services that include vector design, cloning, and packaging. The company also provides solutions for mRNA, plasmid DNA, and lentiviral vectors. With an emphasis on early-stage drug discovery and preclinical development, PackGene Biotech supports researchers in the medical industry by delivering high-purity, high-titer, and high-infectivity vectors for clinical applications. Its capabilities enable scalable and cost-effective production, facilitating advancements in cell and gene therapy trials.

Connect Medical Value is a company based in Hangzhou, Zhejiang, China, that specializes in developing mobile applications for physicians. Founded in 2020, the company focuses on providing a comprehensive platform that integrates clinical services, scientific research, and educational resources. By leveraging advanced artificial intelligence technology, Connect Medical Value aims to enhance the capabilities of healthcare professionals, facilitating improved patient care and medical practice.

Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.

Vibrant Gastro is a company focused on developing and producing a chemical-free vibrating capsule designed to treat constipation. The innovative capsule aims to address the fundamental physiological aspects of constipation, promoting natural bowel activity without relying on chemical supplements or disrupting the body’s internal balance. Leveraging extensive knowledge in gastrointestinal health and motility, Vibrant Gastro offers a novel solution for individuals seeking effective relief from constipation while maintaining a commitment to chemical-free treatment options.

YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.

WeDoctor is a prominent medical health technology platform founded in 2010 by Liao Jieyuan and his team. The company aims to enhance access to healthcare by leveraging technology to provide a comprehensive range of services. Its mobile application allows users to connect with hospitals and doctors, schedule appointments, and access medical advice and ratings for healthcare providers. By integrating both online and offline medical services, WeDoctor aspires to serve as a health management organization, facilitating improved healthcare experiences for millions of families. The platform emphasizes a user-friendly approach to healthcare, making essential medical services readily available and efficient.